Heavy Ion Radiotherapy for Cancer
Indications: Head and neck tumors, bone and soft tissue tumors, esophageal cancer, lung cancer, liver cancer, intrahepatic cholangiocarcinoma, pancreatic cancer, postoperative pelvic recurrence of colorectal cancer, kidney cancer, prostate cancer, cervical cancer, malignant melanoma in the gynecological field, and solitary metastases (lung, liver, or lymph nodes).

Heavy Ion Radiotherapy for Cancer
Indications: Head and neck tumors, bone and soft tissue tumors, esophageal cancer, lung cancer, liver cancer, intrahepatic cholangiocarcinoma, pancreatic cancer, postoperative pelvic recurrence of colorectal cancer, kidney cancer, prostate cancer, cervical cancer, malignant melanoma in the gynecological field, and solitary metastases (lung, liver, or lymph nodes).

Please note that, as general eligibility criteria for heavy ion radiotherapy, patients must meet the following conditions:

The lesion (cancer) is localized and not widespread
The patient is able to remain in a resting supine position for approximately 30 minutes
The target lesion is not adjacent to the gastrointestinal tract
The patient’s general condition is good (Performance Status: 0–2; for bone and soft tissue tumors: 0–3)
There are no active or refractory infections in the planned irradiation area
The patient has been informed of the cancer diagnosis and wishes to undergo heavy ion radiotherapy of their own will

Please note that the indication for heavy ion radiotherapy requires a comprehensive evaluation by specialists. After consultation, the case will be reviewed by a cancer board, and depending on the outcome, the patient may not be considered eligible for this treatment.

Providing Medical Institution

Osaka Heavy Ion Therapy Center (HIMAK)

〒540-0008
3-1-10 Otemae Chuo-ku Osaka City

https://www.osaka-himak.or.jp/

Specialty

heavy ion therapy for cancer

Eligibility Criteria/Exclusions for Treatment

For eligibility assessment and appointment scheduling, the following medical information is required: Referral letter (medical information form) Recent imaging data (preferably within the last 3 months), including CD-R containing images that show chronological changes, along with radiology reports (e.g., CT, MRI, RI, PET-CT) Recent blood test results (preferably within the last 3 months), including data showing chronological changes (e.g., tumor markers, blood urea nitrogen, creatinine levels, infection-related data) Pathology report Pulmonary function test results (required for patients with lung cancer)

Remarks

【Program Introduction Video】 https://www.youtube.com/watch?v=tCdpYxdZqMY

Precautions / Contraindications

The indication for heavy ion radiotherapy requires a comprehensive evaluation by specialists. Following the consultation, the case will be reviewed by a cancer board, and depending on the outcome, the patient may not be considered eligible for heavy ion radiotherapy.